Bladder cancer
Open
Phase 2
This trial is looking at adding a drug called V940 to BCG for people with non muscle invasive bladder cancer.
Non muscle invasive bladder cancer means the cancer cells are only in the inner lining of the bladder.
This trial is for people who have a high risk of their cancer coming back after treatment.
Recruitment start: 19 September 2025
Recruitment end: 12 August 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Bernadett Szabados
Merck Sharp & Dohme Ltd
Last reviewed: 14 May 2026
CRUK internal database number: 20119
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
